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ABSTRACT   
 
Background:  Elevated body mass index (BMI) has been associated with acute kidney 
injury (AKI) in surgical and critically ill patients.  Less is known about the relationship 
between obesity and AKI in the population-based setting.   
 
Study Design:  Prospective cohort study.   
   
Setting & Participants:  Participants of the Atherosclerosis Risk in Communities (ARIC) 
study who attended a study visit between 1996 and 1998.   
 
Predictors:  BMI and waist-to-hip ratio (WHR) at baseline.   
 
Outcome:  AKI occurring during subsequent hospitalizations.     
 
Measurements:  Cox proportional hazards models included the following variables: BMI 
(modeled as a linear spline, with knot at 30 kg/m2), WHR, age, sex, race, hypertension, 
diabetes, coronary artery disease, estimated glomerular filtration rate, and albuminuria.  
Participants were censored at 12/31/2010, death, or end-stage renal disease.   
 
Results:  At baseline, participants’ mean age was 63.3 years, mean BMI was 28.8 kg/m2, 
and mean WHR was 0.92 for women and 0.98 for men.  Over 12 years of follow-up, 824 
participants developed AKI.  There was a U-shaped relationship between BMI and AKI.  
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For BMI > 30 kg/m2, a 1 kg/m2 increase was associated with a 7% increase in risk of AKI 
(adjusted hazard ratio (aHR) 1.07, 95% CI: 1.06, 1.09, p < 0.001); for BMI < 30 kg/m2, a 
1 kg/m2 increase was associated with a 3% decrease in AKI risk (aHR 0.97, 95% CI: 
0.94, 0.99, p = 0.04).  Elevated WHR was linearly associated with AKI.  A 0.01 increase 
in WHR was associated with a 3% increase in risk of AKI (aHR 1.03, 95% CI: 1.01, 
1.04; p < 0.001).   There was no statistically significant interaction between WHR and 
BMI. 
 
Limitations:  BMI and WHR were measured only at baseline.       
 
Conclusions:  In a population-based cohort, higher BMI over 30 kg/m2 and higher WHR 
were independently associated with increased risk of hospitalized AKI.  Obese 
individuals may benefit from strategies to prevent AKI.   
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Obesity has reached epidemic proportions worldwide.  In the United States, nearly 35% 
of adults were obese (BMI ≥ 30 kg/m2) and another 33% were overweight (BMI 25-29.9 
kg/m2) in 2012 (1).  Accompanying the rise in obesity is a rise in prevalence of many 
obesity-related complications, including chronic kidney disease (2-4).  There is some 
evidence to suggest that obese surgical and critically ill patients face higher risk of acute 
kidney injury (AKI) (5-11).  This relationship has not been studied in broader 
populations.  As no specific therapies for AKI are available, prevention of avoidable 
cases is key.  Discovery of new risk factors for AKI may help to identify individuals who 
might benefit from preventive strategies.   
 
Body mass index (BMI) is the most widely utilized measure of obesity, but it may not be 
the best measure of adiposity (12).  Central measures of adiposity, such as waist to hip 
ratio, waist circumference, and waist to height ratio, are thought to be better indicators of 
visceral adiposity (13, 14).  In several studies, one or more central measures of adiposity 
have been shown, independent of BMI, to be associated with outcomes such as all-cause 
mortality (15, 16), cardiovascular disease (17, 18), hypertension (19), and diabetes (20, 
21).  Other studies have shown that central adiposity measures may be better predictors 
of outcomes compared to BMI (22-25).  Whether a measure of abdominal adiposity may 
provide additional information regarding risk of AKI compared to BMI alone is 




The Atherosclerosis Risk in Communities (ARIC) study is a prospective, community-
based cohort of 15,792 participants enrolled between 1987 and 1989.  Using participants 
who presented for visit 4 (1996 to 1998), we examined whether BMI and waist-to-hip 
ratio were risk factors for subsequent hospitalized AKI, independent of established risk 
factors for AKI.  We also evaluated whether the relationship of obesity with AKI 
identified by diagnostic codes (which are known to have low sensitivity) was similar to 
that defined by change in creatinine according to Kidney Disease: Improving Global 







The ARIC study is a prospective, community-based cohort of individuals aged 45 to 64 at 
enrollment from four communities (Washington County, MD; Forsyth County, NC; 
Jackson, MS; and Minneapolis, MN) (26).  A total of 15,792 individuals were initially 
enrolled between 1987 and 1989, and then re-examined at the second (1990-1992), third 
(1993-1995), fourth (1996-1998) and fifth (2011-2013) visits.  Although BMI and WHR 
were measured at each exam, albuminuria (a significant risk factor for AKI) was first 
measured at the fourth exam; thus, the fourth study visit (visit 4) was treated as the 
baseline for the present study.  Of the 11,656 participants attending visit 4, 11,063 were 
included in our analysis.  Participants were excluded for the following reasons:  previous 
episode of AKI or estimated glomerular filtration rate (eGFR) < 15 ml/min/1.73 m2 (N = 
52), missing BMI (N = 38), missing WHR (N = 1), WHR > 1.5 (N = 4), or missing data 
on one or more other covariates (N = 498).   
 
Measurements and Definitions 
  
Weight and height assessed at the baseline visit (visit 4) were used to calculate BMI.  
Obesity was defined as BMI ≥ 30 kg/m2.  Waist and hip circumference were also 
measured at the baseline visit, and WHR was defined as their ratio.  There are no 
universally accepted cut-offs for WHR.  The World Health Organization has reported 
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substantially increased risk of metabolic complications for women with WHR ≥ 0.85 and 
≥ 0.90 for men (27); however, in the ARIC study, > 90% of male participants had a WHR 
≥ 0.90.  Thus, for our analysis, a WHR ≥ 0.85 in women and WHR ≥ 0.95 in men was 
considered elevated.  Diabetes was defined as a single fasting serum glucose ≥ 126ml/dL, 
non-fasting glucose ≥ 200 mg/dL, use of antidiabetic medications, or patient-reported 
diagnosis of diabetes.  Hypertension was defined as systolic blood pressure ≥ 140 mmHg, 
diastolic blood pressure ≥ 90 mmHg (from a mean of two blood pressure measurements), 
or use of antihypertensive agents.  Creatinine was measured by the modified kinetic Jaffe 
method in plasma samples.  Creatinine values were then calibrated to the National 
Institute of Standards and Technology standard, and eGFR was calculated using the CKD 
Epidemiology Collaboration (CKD-EPI) 2009 creatinine equation (28).  Urine albumin to 
creatinine ratio (ACR) was measured from a spot urine sample by a nephelometric 
method.  Albuminuria was defined as ≥ 30 mg of albumin per gram of creatinine; 
moderately increased albuminuria was defined as 30-300 mg of albumin per gram of 
creatinine and severely increased albuminuria was defined as > 300 mg of albumin per 




After enrollment, ARIC participants were followed prospectively for hospitalizations via 
annual phone interviews (> 90% contact rate at 20 years) and active surveillance of 
discharge lists from community hospitals.  At least 26 distinct diagnostic codes were 
abstracted from discharge documentation.  Deaths were identified through active 
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surveillance of local newspaper obituaries, state death lists and death certificates from the 
Department of Vital Statistics.  International Classification of Diseases, 10th Revision, 
Clinical Modification (ICD-10-CM) codes were abstracted from death certificates.  
Hospitalization with AKI was defined as the presence of one of the following codes 
among the discharge diagnoses or causes of death:  International Classification of 
Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes 584.x and ICD-10-CM 
codes N17.x.  This approach has been previously shown to have high specificity (99.6%) 
but low to moderate sensitivity (17.4% for any AKI, 40.3% for stage 2-3 AKI) compared 
to creatinine-based methods using KDIGO criteria (29).  AKI hospitalizations that 




Baseline characteristics of participants were compared by obesity status (BMI < 30 kg/m2 
and ≥ 30 kg/m2), and normal and elevated WHR (elevated WHR defined as ≥ 0.85 for 
women and ≥ 0.95 for men) using χ2 and t tests.  The association of BMI, WHR and 
hospitalized AKI, was modeled using Cox proportional hazards regression.  Hazard ratios 
were determined for each 1 kg/m2 change in BMI and each 0.01 increase in WHR as each 
represented approximately 15% of their respective standard deviations.  Because a non-
linear relationship between BMI and hospitalized AKI was observed, BMI was modeled 
as a linear spline with knot at 30 kg/m2.  In locally-weighted smoothing plots, WHR 
demonstrated a fairly linear relationship with hospitalized AKI and thus was modeled as 
a continuous linear variable.  Participants were censored at December 31, 2010, or at the 
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time of incident end-stage renal disease or death.  Analyses were adjusted for age, sex, 
race, eGFR (modeled as a linear spline with knot at 60 ml/min/1.73 m2), log ACR, 
hypertension, diabetes, and coronary heart disease.  To determine whether the 
relationship between WHR and AKI varied by obesity status, an interaction between 
obesity and WHR was tested.  To evaluate the robustness of the associations by CKD 
status, analyses were repeated in participants with and without CKD (defined as eGFR < 
60 ml/min/1.73 m2 or eGFR > 60 ml/min/1.73 m2 with albuminuria).   
 
Several sensitivity analyses were also conducted.  First, to assess whether an obesity-AKI 
association might be driven by the higher frequency of hospitalizations in obese 
compared to non-obese participants, we included the number of hospitalizations as a 
time-varying covariate in our model.  Second, to assess whether the relationship was 
simply driven by a higher rate of cardiac interventions in obese participants, we repeated 
analyses excluding AKI events occurring during cardiac procedures (ICD-9-CM codes 
00.66, 35.x through 39.x).  Third, because diagnostic codes tend to have low sensitivity in 
the identification of AKI, we repeated analyses in a subset of ARIC participants from 
Washington County, MD, for whom we had access to system-wide data from the Meritus 
Health System, identifying AKI cases based on the KDIGO creatinine-based criteria.  
Finally, to evaluate whether the obesity-AKI relationship was simply driven by more 
rapid CKD progression among obese compared to non-obese participants, we modeled 
the association between BMI, WHR and hospitalized AKI in the subset of Washington 
County participants using time-varying eGFR as a covariate.  All statistical analyses were 






To evaluate the association of waist circumference (WC) and hospitalized AKI, Cox 
proportional hazards regression was also used to model the association between BMI, 
WC and hospitalized AKI.  Models were adjusted for the same covariates mentioned 
above.  An interaction between BMI and WC was also tested.  Subgroup analysis and 











Baseline Characteristics of Participants 
 
Among the 11,063 participants in the study population, 824 (7.5%) developed 
hospitalized AKI over a mean follow up of 12.0 years (standard deviation (SD) 3.1 
years).  Over a third (35%) of participants were obese (BMI ≥ 30 kg/m2) at baseline, and 
78% of participants had an elevated WHR.  Compared to non-obese participants, 
participants with a BMI ≥ 30 kg/m2 were slightly younger, more often female, and more 
often black; they were also more likely to have diabetes, hypertension, eGFR < 60 
ml/min/1.73 m2, and albuminuria (Table 1).  Despite a higher proportion of participants 
with eGFR < 60 ml/min/1.73 m2, mean eGFR was slightly higher in the obese group.  
Compared to participants with normal WHR, participants with elevated WHR were 
slightly older, and more often white; they were also more likely to have diabetes, 
hypertension, eGFR < 60 ml/min/1.73 m2, and albuminuria.  Interestingly, there was no 
difference in prevalent coronary heart disease by BMI or WHR.  There was also a 
substantial number of participants with abnormal BMI and normal WHR, and vice versa: 
the proportion of participants with elevated BMI was 11.0% among those with normal 
WHR, and 58.4% of those with elevated WHR had BMI < 30 kg/m2.    
 




In unadjusted analysis, higher baseline BMI was significantly associated with 
hospitalized AKI.  Below 30 kg/m2, each 1 kg/m2 increase in BMI was associated with a 
3% increase in risk of hospitalized AKI (hazard ratio (HR) 1.03, 95% CI: 1.01, 1.06, p = 
0.02).  Above 30 kg/m2, each 1 kg/m2 increase in BMI was associated with a 7% increase 
in risk of hospitalized AKI (HR 1.07, 95% CI: 1.06, 1.09, p <0.001).  In adjusted analysis 
(including adjustment for WHR), there was a U-shaped relationship between BMI and 
hospitalized AKI, with the risk of hospitalized AKI decreasing for each 1 kg/m2 increase 
in BMI below 30 kg/m2 (adjusted HR (aHR) 0.97, 95% CI: 0.94, 1.00, p = 0.04) but 
increasing for each 1 kg/m2 increase in BMI above 30 kg/m2 (aHR 1.07, 95% CI: 1.06, 
1.09, p <0.001) (Figure 1).  All covariates included in the full model were also 
significantly associated with hospitalized AKI.   
 
In unadjusted analysis, higher WHR was also associated with hospitalized AKI (per 0.01 
increase, HR 1.06, 95% CI: 1.05, 1.07, p <0.001).  In adjusted analysis, each 0.01 
increase in WHR was associated with a 3% increase in risk of hospitalized AKI (aHR 
1.03, 95% CI: 1.01, 1.04, p <0.001).   This association was seen in both men and women 
(Figure 2).  The relationship between WHR and AKI was significant in obese 
populations and marginally significant in non-obese populations (for obese participants, 
aHR 1.03, 95% CI 1.01, 1.06, p = 0.002; for non-obese participants, aHR 1.02, 95% CI 
1.00, 1.03, p = 0.05; p for interaction = 0.4).  Demographic adjusted AKI incidence was 
lowest among participants with BMI < 25 kg/m2 and WHR below the cutoff and highest 






When stratified by CKD (defined as eGFR < 60 ml/min/1.73 m2 or eGFR ≥ 60 
ml/min/1.73 m2 with albuminuria), hazard ratios for BMI > 30 kg/m2 and hospitalized 
AKI were similar to those for the entire cohort (Table 2).  Increasing BMI below 30 
kg/m2 was protective only among participants with CKD; there was no association 
between BMI and hospitalized AKI among non-obese participants without CKD.  
However, a formal test for interaction between BMI and CKD was not statistically 
significant (p = 0.4).  The association of WHR and hospitalized AKI was similar in the 
subgroups, although not significant among those with CKD, likely due to small sample 




When number of hospitalizations was included as a time-varying covariate, the 
association between BMI and WHR with hospitalized AKI were similar to the original 
model (Table 4).  Associations were also similar when excluding the 85 participants with 
AKI occurring concomitant with a cardiac procedure.  In the subset of 2,486 participants 
who had at least one encounter in the Washington County Meritus Heath System, 290 
cases of AKI were identified using KDIGO creatinine-based criteria.  The association 
between BMI ≥ 30 kg/m2, WHR, and AKI were similar, although an association of BMI 
< 30 kg/m2 and hospitalized AKI was no longer observed.  Using the same Washington 
County subset and adjusting for eGFR as a time-varying covariate produced similar 
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results, although the association of WHR with hospitalized AKI did not reach statistical 
significance.  There was little difference in the associations between baseline eGFR and 
hospitalized AKI and time-varying eGFR and AKI (aHR for each 1 ml/min/1.73 m2 
increase in baseline eGFR < 60 ml/min/1.73 m2 0.95, 95% CI: 0.93, 0.97, p < 0.001; aHR 
for each 1 ml/min/1.73 m2 increase in time-varying eGFR < 60 ml/min/1.73 m2 0.96, 
95% CI: 0.95, 0.97, p <0.001).  
 
Analyses Involving Waist Circumference 
 
In unadjusted analysis, WC was associated with hospitalized AKI.  Each 2.5 cm increase 
in WC was associated with a 7% increase in risk of AKI (HR 1.07, 95% CI: 1.06, 1.08, p 
<0.001).  In adjusted analysis, each 2.5 cm increase in WC was associated with a 5% 
increase in risk of hospitalized AKI (aHR 1.05, 95% CI: 1.05, 1.10, p <0.001).  In 
subgroup and sensitivity analyses, WC was not as consistently associated with AKI in 
comparison to WHR.   





In this community-based study of 11,063 participants followed for an average of 12 
years, both BMI and WHR were independently associated with hospitalized AKI.  While 
the relationship between WHR was linear, in adjusted analyses, there was a U-shaped 
relationship between BMI and hospitalized AKI.  At BMI ≥ 30 kg/m2, higher BMI was 
associated with higher AKI risk.  Paradoxically, at BMI <30 kg/m2, higher BMI was 
associated with lower AKI risk, although this relationship was significant only among 
persons with baseline CKD.  These results suggest that obese individuals and individuals 
with high WHR should be considered to have increased risk of developing AKI.   
 
This study extends on prior studies that demonstrated a significant relationship between 
obesity and AKI in various clinical populations.  Druml et al studied 5,232 patients in 
intensive care units and found the odds of AKI requiring renal replacement therapy were 
increased 1.35 times higher in patients who were overweight, and 2.54 times higher in 
patients who were obese, compared to normal weight patients (6).  Billings et al studied 
445 patients undergoing cardiac surgery and found that the odds of AKI (stage I or worse 
by Acute Kidney Injury Network (AKIN) criteria) increased 26.5% for each 5 kg/m2 
increase in BMI (5).  Shashaty et al studied 400 critically ill trauma patients and found 
that a BMI > 30 kg/m2 was associated with an odds ratio of 4.72 for developing AKI (by 
AKIN criteria) (7).  Our study adds to this body of literature by demonstrating a 
significant relationship between BMI and AKI in a large, population-based cohort.  In 
addition, we report an interesting nuance: a slightly protective effect of higher BMI up to 
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30 kg/m2, particularly in participants with preexisting CKD.  This observation may be 
analogous to decreased mortality rates seen among overweight and mildly obese 
individuals in the general population (15) and in those with coronary artery disease (30).   
 
Several potential mechanisms might link obesity to kidney injury.  Obesity is associated 
with increased production of adipokines, proinflammatory cytokines, and markers of 
oxidative stress (5, 31, 32).  These have been linked to acute kidney injury, although the 
mechanisms of injury have yet to be elucidated.  Obese individuals may be more 
susceptible to volume depletion due to difficulty with assessment of volume status, or 
they may be more likely to receive supratherapeutic doses of nephrotoxic medications 
such as antibiotics given uncertainty regarding appropriate dosing (31).  A possible 
explanation for the independent association of WHR even after adjustment of BMI, is 
that both conditions may lead to increased sagittal abdominal diameter and intra-
abdominal pressure (33, 34), which has been shown to be associated with AKI (35).   
 
There are several strengths and limitations of this study.  This is the first large, population 
based study of AKI with baseline BMI and WHR measured prior to hospitalization for 
AKI.  Few, if any, studies have assessed WHR or WC as a risk factor for AKI.  All data 
were collected prospectively, and hospitalization data were gathered by active 
surveillance, limiting the number of missed hospitalizations.  A particular strength of this 
study was the availability of additional health system data for the subset of participants 
from Washington County, MD.  As such, we were able to test the robustness of our 
results to using creatinine-based definitions of AKI and time-varying measures of eGFR, 
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one of the strongest risk factors for AKI.  These sensitivity analyses showed the 
association of higher BMI and elevated WHR with hospitalized AKI to be very robust.  
The association of BMI and WC with hospitalized AKI was less robust, likely due to the 
significant correlation between BMI and WC.  Limitations of our study included the low 
rate of hospitalizations for AKI among ARIC participants.  BMI and WHR were 
measured only once at baseline.  In addition, only a minority of participants had a WHR 
below the WHO cut-off which, while potentially limiting our ability to precisely 
characterize the association between WHR and AKI, may more accurately reflect the 
U.S. population.  As in all observational studies, the relationship between obesity, 
elevated WHR, and AKI may simply represent confounding, whereby obesity and 
elevated WHR are present in sicker individuals, who are at higher risk for AKI. 
 
In summary, this study demonstrates an association of elevated BMI and higher WHR 
with hospitalized AKI independent of baseline kidney function and other known risk 
factors for AKI.  This suggests that in addition to overall adiposity, weight distribution 
may be important in determining risk of AKI.  Strategies to prevent AKI should be 
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p-value < 30 kg/m2 
(N = 7,193) 
≥ 30 kg/m2 
(N = 3,870) 
Below cut-off 
(N = 2,396) 
Elevated 
(N = 8,667) 
Mean age (SD) 63.6 (5.7) 62.8 (5.5) < 0.001 62.6 (5.7) 63.5 (5.6) < 0.001 
Male (%) 46.2 40.1 < 0.001 55.2 41.0 < 0.001 
Black (%) 17.6 30.2 < 0.001 25.2 21.1 < 0.001 
Diabetes (%) 11.3 26.8 < 0.001 8.3 19.1 < 0.001 
Hypertension (%) 40.9 59.0 < 0.001 36.1 50.3 < 0.001 
Coronary heart 
disease (%) 
8.4 8.4 0.9 8.3 8.4 0.8 
Mean eGFR in ml/ 
min/1.73 m2 (SD) 
86.1 (15.1) 86.9 (17.1) 0.009 86.9 (15.0) 86.2 (16.0) 0.05 
eGFR < 60ml/ 
min/1.73 m2 (%) 
5.6 7.1 0.001 4.5 6.6 < 0.001 







5.7 8.1 5.0 7.0 
Severely increased 
albuminuria4 (%) 
1.3 2.2 0.9 1.8 
BMI ≥ 30 kg/m2 0 100 N/A 11.0 41.6 < 0.001 
1BMI and WHR examined independently in 11,063 participants  
2Waist-to-hip ratio cut-off for women was 0.85, for men 0.95. 
330-30 mg of albumin/gram of creatinine. 





Table 2.  Cox Proportional Hazard Ratios for Hospitalization for AKI, Overall 
and by CKD Status 
Group N 
aHR (95% CI); p-value 
BMI < 30 kg/m2 BMI ≥ 30 kg/m2 WHR 
Whole cohort 11,063 
0.97 (0.94, 1.00); 
0.04 
1.07 (1.06, 1.09); 
<0.001 
1.03 (1.01, 1.04); 
<0.001 
eGFR < 60ml/min/1.73 m2 or eGFR ≥ 60ml/min/1.73 m2 with ACR ≥ 30 mg/g  
   No 9,659 
0.98 (0.95, 1.02);  
0.4 
1.08 (1.05, 1.10); 
<0.001 
1.03 (1.01, 1.04); 
0.002 
   Yes 1,404 
0.94 (0.90, 0.99);  
0.02 
1.07 (1.03, 1.10); 
<0.001 






Table 3.  AKI Incidence (95% CI) by BMI and WHR (per 1,000 person years) 
 BMI 
< 25 kg/m2 25-29.9 kg/m2 ≥ 30kg/m2 
WHR 
Below cut-off 2.9 (2.1, 3.6) 3.0 (2.0, 4.0) 4.2 (2.2, 6.2) 
Elevated 3.6 (2.8, 4.4) 4.2 (3.3, 4.5) 6.3 (5.5, 7.2) 





Table 4.  Cox Proportional Hazard Ratios for Hospitalization for AKI for Sensitivity Analyses 
Group N 
aHR (95% CI); p-value 
BMI < 30 kg/m2 BMI ≥ 30 kg/m2 WHR 
Whole cohort 11,063 
0.97 (0.94, 1.00); 
0.04 
1.07 (1.06, 1.09); 
<0.001 
1.03 (1.01, 1.04); 
<0.001 
Addition of hospitalizations 
as time varying covariate 
11,063 
0.97 (0.94, 1.00); 
0.08 
1.07 (1.05, 1.09); 
<0.001 
1.03 (1.01, 1.04); 
0.001 
Exclusion of AKI occurring 
during hospitalizations with 
cardiac procedure 
10,978 
0.96 (0.93, 0.99); 
0.01 
1.08 (1.06, 1.10); 
<0.001 
1.03 (1.01, 1.04); 
<0.001 
Identification of AKI using 
KDIGO creatinine criteria 
in Washington County 
participants 
2,486 
1.00 (0.95, 1.05); 
0.9 
1.05 (1.02, 1.08); 
0.002 
1.03 (1.00, 1.06); 
0.02 
Addition of eGFR as time 




1.00 (0.95, 1.05); 
0.9 
1.07 (1.04, 1.10); 
<0.001 
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Figure 2.  Relationship between WHR and Relative Hazard for Hospitalization with AKI  
a.  Among Women 
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